Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Alberta
$27,000.00
Impact of Sarcopenia on Post-Operative Complications and Oncologic Outcomes in Lung Cancer
EF 2025-26
Résumé
Lung cancer is the leading cause of cancer mortality in Canada. As society ages, older and more frail patients are being diagnosed with lung cancer and surgeons must provide such patients with treatment that is likely to be of benefit while minimizing harms. To this end, identifying pragmatic tools that help predict which patients will benefit from invasive treatments is a clinical priority.
Sarcopenia is a condition of reduced muscle mass and function that is seen in many cancers, including lung cancer. Lung cancer patients with sarcopenia are more likely to experience post-operative complications and cancer progression or recurrence after treatment.
My research seeks to better understand the association between lung cancer, sarcopenia, and patient outcomes. My research focuses specifically on respiratory sarcopenia, a condition where reduced muscle mass is accompanied by reduced respiratory function. We hypothesize that respiratory sarcopenia will be able to better predict post-operative complications, cancer recurrence and reduced survival than sarcopenia alone.
The study will include patients treated under the Division of Thoracic Surgery at the Royal Alexandra Hospital. Sarcopenia and respiratory function will be measured using routine pre-operative computed tomography and pulmonary function testing, respectively. A historical cohort will be analyzed to compare disease recurrence and overall survival in patients with and without respiratory sarcopenia. A prospective cohort will be followed to assess differences in post-operative complications between those with and without respiratory sarcopenia. This research hopes to aid in surgical decision making and therapy planning for patients with lung cancer undergoing surgery.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
572988
Name
Morris-Janzen Dunavan
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Impact of Sarcopenia on Post-Operative Complications and Oncologic Outcomes in Lung Cancer
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Disease-Free Survival; Lung Cancer; Lung Resection; Overall Survival; Post-Operative Complications; Pulmonary Function Testing; Respiratory Sarcopenia; Skeletal Muscle Index; Thoracic Surgery; Thoracic Surgical Oncology
Abstract
Lung cancer is the leading cause of cancer mortality in Canada. As society ages, older and more frail patients are being diagnosed with lung cancer and surgeons must provide such patients with treatment that is likely to be of benefit while minimizing harms. To this end, identifying pragmatic tools that help predict which patients will benefit from invasive treatments is a clinical priority.
Sarcopenia is a condition of reduced muscle mass and function that is seen in many cancers, including lung cancer. Lung cancer patients with sarcopenia are more likely to experience post-operative complications and cancer progression or recurrence after treatment.
My research seeks to better understand the association between lung cancer, sarcopenia, and patient outcomes. My research focuses specifically on respiratory sarcopenia, a condition where reduced muscle mass is accompanied by reduced respiratory function. We hypothesize that respiratory sarcopenia will be able to better predict post-operative complications, cancer recurrence and reduced survival than sarcopenia alone.
The study will include patients treated under the Division of Thoracic Surgery at the Royal Alexandra Hospital. Sarcopenia and respiratory function will be measured using routine pre-operative computed tomography and pulmonary function testing, respectively. A historical cohort will be analyzed to compare disease recurrence and overall survival in patients with and without respiratory sarcopenia. A prospective cohort will be followed to assess differences in post-operative complications between those with and without respiratory sarcopenia. This research hopes to aid in surgical decision making and therapy planning for patients with lung cancer undergoing surgery.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Morris-Janzen, Dunavan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~